Consistent with these data from the pivotal trials, preliminary evidence from studies of early adoption of oral semaglutide in the US also suggests real-world improvements in glycemic control, with a mean HbA 1c reduction of 0.9% observed across patients [85, 86]
The complaint alleges that, in reality, defendants understated the ongoing impact of the personalization exception to the compounded GLP-1 exclusion, overstated the likelihood that patients would switch to Novo's branded alternatives, and overstated the GLP-1 market's expansion or Novo's ability to penetrate it to achieve continued growth
A sterile water multi-draw preparation refers to a highly purified, pyrogen-free water source designed to facilitate repeated withdrawals while maintaining structural integrity
Exercise and Statin-Fibrate Combination Therapy-Caused Myopathy
doi: 10.1210/endo.139.4.5921 48 NauckMABartelsEOrskovCEbertRCreutzfeldtW